Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cuomo

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Psychiatry Research|April 27, 2026
Faster and greater antidepressant response to intravenous ketamine in bipolar compared with unipolar treatment-resistant depression: Diagnostic and sex-related findings from a naturalistic studyPietro Carmellini, Andrea Fagiolini, Mario Pinzi, et al.
Frontiers in Psychiatry|April 20, 2019
Prevalence and Correlates of Vitamin D Deficiency in a Sample of 290 Inpatients With Mental IllnessAlessandro Cuomo, Giuseppe Maina, Simone Bolognesi, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 31, 2022
Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patientsLudovico Mineo, Alessandro Rodolico, Giorgio Alfredo Spedicato, et al.
Cell Reports|September 21, 2022
Targeting the USP7/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC/LSD1 inhibitorsLetizia Granieri, Federica Marocchi, Marine Melixetian, et al.
British Journal of Clinical Pharmacology|January 8, 2026
Can we identify a post-Serenoa syndrome (PSS)? A case series on sexual and psychiatric side effects of Serenoa repensFilippo Firenzuoli, Bernardo Firenzuoli, Vittorio Mascherini, et al.
Bipolar Disorders|March 31, 2025
Ultra High Dose (252 mg/Day) Lorazepam Infusion for Delirium in a Patient With Bipolar Disorder, TBI and Substance Withdrawal in ICUFrancesco Fargnoli, Valentina Lo Serro, Pasquale D'onofrio, et al.
Psychopharmacology|August 22, 2020
Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate releaseGiovanni Martinotti, Stefano Barlati, Davide Prestia, et al.
Genes & Development|December 13, 2023
Restrictor synergizes with Symplekin and PNUTS to terminate extragenic transcriptionMarta Russo, Viviana Piccolo, Danilo Polizzese, et al.
Expert Opinion on Pharmacotherapy|November 18, 2022
Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practiceAndrea Fiorillo, Alessandro Cuomo, Gaia Sampogna, et al.
Frontiers in Pharmacology|October 31, 2018
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and ReviewAlessandro Cuomo, Giuseppe Maina, Gianluca Rosso, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Psychiatry Research|April 27, 2026
Faster and greater antidepressant response to intravenous ketamine in bipolar compared with unipolar treatment-resistant depression: Diagnostic and sex-related findings from a naturalistic studyPietro Carmellini, Andrea Fagiolini, Mario Pinzi, et al.
Frontiers in Psychiatry|April 20, 2019
Prevalence and Correlates of Vitamin D Deficiency in a Sample of 290 Inpatients With Mental IllnessAlessandro Cuomo, Giuseppe Maina, Simone Bolognesi, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 31, 2022
Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patientsLudovico Mineo, Alessandro Rodolico, Giorgio Alfredo Spedicato, et al.
Cell Reports|September 21, 2022
Targeting the USP7/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC/LSD1 inhibitorsLetizia Granieri, Federica Marocchi, Marine Melixetian, et al.
British Journal of Clinical Pharmacology|January 8, 2026
Can we identify a post-Serenoa syndrome (PSS)? A case series on sexual and psychiatric side effects of Serenoa repensFilippo Firenzuoli, Bernardo Firenzuoli, Vittorio Mascherini, et al.
Bipolar Disorders|March 31, 2025
Ultra High Dose (252 mg/Day) Lorazepam Infusion for Delirium in a Patient With Bipolar Disorder, TBI and Substance Withdrawal in ICUFrancesco Fargnoli, Valentina Lo Serro, Pasquale D'onofrio, et al.
Psychopharmacology|August 22, 2020
Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate releaseGiovanni Martinotti, Stefano Barlati, Davide Prestia, et al.
Genes & Development|December 13, 2023
Restrictor synergizes with Symplekin and PNUTS to terminate extragenic transcriptionMarta Russo, Viviana Piccolo, Danilo Polizzese, et al.
Expert Opinion on Pharmacotherapy|November 18, 2022
Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practiceAndrea Fiorillo, Alessandro Cuomo, Gaia Sampogna, et al.
Frontiers in Pharmacology|October 31, 2018
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and ReviewAlessandro Cuomo, Giuseppe Maina, Gianluca Rosso, et al.
Pageof 18